Of clinical relevance, active AKT has been found only in CD28neg antigen-specific CD8+ T cell clones obtained from melanoma patients who benefit from chemo-immunotherapy combined treatment, suggesting that its activation might be dependent on DNA-directed effects of alkylating agents. This evidence concerns the gene CD8A and melanoma.